Premium
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives
Author(s) -
Hodowanec Aimee C.,
Pikis Andreas,
Komatsu Takashi E.,
Sampson Mario R.,
Younis Islam R.,
O'Rear Julian J.,
Singer Mary E.
Publication year - 2019
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1363
Subject(s) - cytomegalovirus , medicine , cytomegalovirus infection , intensive care medicine , disease , immunology , hematopoietic cell , human immunodeficiency virus (hiv) , haematopoiesis , human cytomegalovirus , stem cell , viral disease , virus , herpesviridae , biology , genetics
This review summarizes the significant impact of cytomegalovirus (CMV) infection on solid organ and hematopoietic stem cell transplant recipients. A discussion of the various CMV prevention and treatment strategies is provided, including a detailed description of each of the available CMV antiviral drugs.